TNF-alpha and IL-1-alpha injected into rat brains both raised pain thresholds, with TNF-alpha's painkilling effect partly blocked by the opioid blocker naloxone.
P < 0.001Both immune cytokines significantly increased pain thresholds when administered centrally in rats
What the researchers found
Central TNF-alpha and IL-1-alpha both increased nociceptive thresholds. TNF-alpha decreased locomotion. Naloxone partially reversed TNF-alpha's analgesic effect.
Why it matters
This links the immune system directly to brain pain control. During infection or inflammation, cytokines in the brain may change pain sensitivity, which could explain pain changes during illness.
How the study worked
Rats received intracerebroventricular injections of TNF-alpha or IL-1-alpha. Pain thresholds were tested using the hot-plate method. Locomotor activity was recorded. Naloxone was used to test opioid involvement.
What this study cannot tell us
Animal study with direct brain injection. Doses may not reflect natural cytokine levels during inflammation. Acute effects only studied.
How to read the evidence
Preliminary — an animal study using direct brain injection of cytokines at potentially non-physiological doses. Demonstrates mechanism but needs further validation.
When this study was published
Published in 1992 (34 years ago). The neuroimmune-pain connection discovered here has since become a major research field.
The bigger picture
When you're sick, your brain chemistry changes — and part of that involves immune molecules activating the brain's own painkilling system. This helps explain why pain perception shifts during illness and inflammation.
Questions still open
- Could chronic inflammation lead to lasting changes in the brain's opioid pain system?
- Do anti-inflammatory drugs indirectly affect pain by reducing these cytokine-opioid interactions?
Common questions
How do immune molecules affect pain?
Why does this matter for chronic pain?
Read the original research
Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity.
Neuroscience letters, 148(1-2), 76-80
Citation
Bianchi, M; Sacerdote, P; Ricciardi-Castagnoli, P; Mantegazza, P; Panerai, A E. (1992). Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity.. Neuroscience letters, 148(1-2), 76-80.